Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) saw unusually-strong trading volume on Wednesday . Approximately 62,176 shares changed hands during mid-day trading, a decline of 90% from the previous session’s volume of 608,264 shares.The stock last traded at $23.91 and had previously closed at $23.61. Several research analysts have recently weighed in on […]
Marshall Wace LLP bought a new position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) during the third quarter, according to its most recent filing with the SEC. The firm bought 52,307 shares of the company’s stock, valued at approximately $1,268,000. Several other institutional investors and hedge funds have also recently modified their holdings of […]